Focus On Quality Of Life And Costs In Patients With Iron Deficiency And Heart Failure

MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA(2018)

引用 0|浏览2
暂无评分
摘要
Chronic heart failure is an important health problem worldwide. Despite the reduction in mortality associated with the newest medical and interventional treatments, the quality of life remains an important concern for patients as well for doctors. Aim: to quantify the quality of life and the financial burden in patients with heart failure and iron deficiency. Material and methods: Patients with heart failure and iron deficiency were included in the study. Personal medical data were collected, and the patients completed the Kansas City Cardiomyopathy Questionnaire (KCCQ), which is a validated questionnaire for anemia associated with heart failure. The financial costs of hospital admission were evaluated. Results: A statistically significant moderate direct correlation between calcium channel blockers treatment and the scores in KCCQ was found. Also, a statistically significant, indirect correlation was shown between anticoagulant treatment and quality of life. As to the financial burden, the average cost per admission was 3,641.75 RON +/- 1,881.32 RON (783.17 euro +/- 404.58 euro). Conclusions: Anticoagulant treatment in patients with heart failure and iron deficiency was associated with reduced quality of life. Calcium channel blockers were associated with improvement of the quality of life in this category of patients.
更多
查看译文
关键词
HEART FAILURE, IRON DEFICIENCY, QUALITY OF LIFE, MEDICAL COSTS
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要